# Dominion Fertility & Endocrinology – FDA Inspection, Jan 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/dominion-fertility-endocrinology/d2ee6e95-7d4b-427c-9170-46afe98e6334
Source feed: FDA_Inspections

> FDA inspection 1195526 of Dominion Fertility & Endocrinology, January 24, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 1271. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195526
- Company Name: Dominion Fertility & Endocrinology
- Inspection Date: 2023-01-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1256409 - 2024-12-06](https://www.keypedia.com/records/fda_inspections/dominion-fertility-endocrinology/7ae6b61b-6b2a-44d0-9c5f-286ec66ad62a)
- FDA Inspection 1099658 - 2019-07-18
- FDA Inspection 1004633 - 2017-02-01
- FDA Inspection 906087 - 2014-11-25
- FDA Inspection 815120 - 2013-01-14

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/la-tasha-m-gunter/db9cd9cf-db0a-4c31-9f7c-24760750f34d)

Company: https://www.keypedia.com/companies/dominion-fertility-endocrinology/f9649f49-2220-4f19-bc68-a03ca89628fc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
